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Female and male very elderly intensive patients (VIPs) might differ in characteristics and outcomes. 
We aimed to compare female versus male VIPs in a large, multinational collective of VIPs with regards 
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to outcome and predictors of mortality. In total, 7555 patients were included in this analysis, 3973 
(53%) male and 3582 (47%) female patients. The primary endpoint was 30‑day‑mortality. Baseline 
characteristics, data on management and geriatric scores including frailty assessed by Clinical Frailty 
Scale (CFS) were documented. Two propensity scores (for being male) were obtained for consecutive 
matching, score 1 for baseline characteristics and score 2 for baseline characteristics and ICU 
management. Male VIPs were younger (83 ± 5 vs. 84 ± 5; p < 0.001), less often frail (CFS > 4; 38% versus 
49%; p < 0.001) but evidenced higher SOFA (7 ± 6 versus 6 ± 6 points; p < 0.001) scores. After propensity 
score matching, no differences in baseline characteristics could be observed. In the paired analysis, 
the mortality in male VIPs was higher (mean difference 3.34% 95%CI 0.92–5.76%; p = 0.007) compared 
to females. In both multivariable logistic regression models correcting for propensity score 1 (aOR 
1.15 95%CI 1.03–1.27; p = 0.007) and propensity score 2 (aOR 1.15 95%CI 1.04–1.27; p = 0.007) male 
sex was independently associated with higher odds for 30‑day‑mortality. Of note, male gender was 
not associated with ICU mortality (OR 1.08 95%CI 0.98–1.19; p = 0.14). Outcomes of elderly intensive 
care patients evidenced independent sex differences. Male sex was associated with adverse 30‑day‑
mortality but not ICU‑mortality. Further research to identify potential sex‑specific risk factors after 
ICU discharge is warranted.
Trial registration: NCT03134807 and NCT03370692; Registered on May 1, 2017 https ://clini caltr ials.
gov/ct2/show/NCT03 37069 2.
Patients 80 years of age and older, who are admitted to the intensive care unit (ICU) consume a large propor-
tion of health care resources and yet continue to suffer from high  mortality1–3. Detailed knowledge of these very 
elderly intensive patients (VIPs) could help to perform better risk stratification and ultimately guide clinicians 
in whom to admit or whom not to admit to the ICU. The Clinical Frailty Scale (CFS), evaluating frailty through 
a simple clinical assessment, has been shown to adequately risk-stratify such elderly  patients4,5.
For several medical conditions, including acute myocardial infarction, gender outcome disparities have 
been  reported6. However, some studies investigated gender differences in ICU patients, and have found distinct 
 differences7,8. Male and female intensive care patients differ with regards to baseline characteristics, risk distribu-
tion and admission diagnoses and these differences may influence  outcomes9,10. Male sex was linked to adverse 
outcomes in a sub-set of VIPs with  sepsis10,11. On the other hand, female sex was reported to be independently 
associated with the decision to withdraw or withhold intensive  care12. Recently, the FROG-ICU evaluated sur-
vival in critically ill patients and reported a trend towards higher survival in elderly women compared to male 
 patients13.
We, therefore, aimed to compare male versus female VIPs with regards to the distribution of risk factors, 
potential differences in management, and outcome as well as predictors of mortality with special emphasis on 
frailty. The main goal with this study using data from two recent large, multinational studies of VIPs was to 
compare male and female patients with regards to crude unadjusted und adjusted baseline characteristics and 
 outcomes4,14,15.
Methods
Study subjects. VIP1 and VIP2 were prospective, multicenter studies, registered on ClinicalTrials.gov 
(ID: NTC03134807, NCT03370692). Both studies included very old intensive care patients (VIPs), defined as 
patients admitted to an ICU and being aged 80 years or older. These patients have been analyzed in other con-
texts and methods and results have been published  previously4,5,16. In summary, for VIP1, each participating ICU 
could include either consecutive patients during three months or the first 20 consecutive patients fulfilling the 
inclusion criteria (all patients 80 of age or older). Data were collected between October 2016 and February 2017. 
For VIP2, VIPs were included from May 2018 to May 2019. All methods were carried out in accordance with 
relevant guidelines and regulations. All experimental protocols were approved by the local institutional and/or 
licensing committees. Informed consent was obtained from all subjects if not omitted by the ethics vote.
In this post-hoc analysis of these two prospective trials, all patients admitted acutely (non-electively) with 
complete data on age, gender, clinical frailty score (CFS) frailty score and sequential organ failure assessment 
(SOFA) score and 30-day-mortality were included (Supplemental Fig. 1). Elective patients from VIP1 were spe-
cifically excluded as they significantly differ from acutely admitted patients in risk distribution and outcomes 
as previously  shown17. The primary endpoint of this study was 30-day-mortality. Frailty was assessed by CFS 
and the respective visual and simple description which were used with  permission18–20. For the patients of the 
VIP2 trial Katz activities of daily living (Katz ADL) with ADL score ≤ 4 defining disability and Short form of 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), with IQCODE ≥ 3.5 defining cogni-
tive decline were  assessed18–20.
Statistical analysis. Continuous data points are expressed as mean ± standard deviation (SD) or 
median ± interquartile range depending on distribution. Differences between independent groups were calcu-
lated using student’s T-test or Mann Whitney U-test accordingly. Categorical data are expressed as numbers 
(percentage). Chi-square test was applied to calculate differences between groups and McNemar’s test for paired 
survival data.
Two propensity scores for being male were calculated (Fig. 1). Propensity score 1 included age (per year), 
CFS score (per point), SOFA score (per point), location (Western Europe, Eastern Europe, Non-European) and 
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admission diagnosis (respiratory failure, circulatory failure, combined respiratory and circulatory failure, sepsis, 
multi-trauma with and without head injury, isolated head injury, intoxication, cerebral injury without trauma, 
emergency surgery, other). Propensity score 2 included all items of propensity score 1 plus the non-baseline 
variables use of vasoactive drugs, of renal replacement therapy, of intubation, of non-invasive ventilation (NIV) 
as well as the decision to limit life-sustaining treatment (withdrawal and/or withholding). Two matched cohorts, 
matching males 1:1 to females, for (1) propensity score 1 and (2) propensity score 2 were obtained using “nearest 
neighbor” matching, the maximum allowed distance was a Δ in propensity score 1 or 2 of 0.001. The matching 
significantly reduced differences in baseline characteristics and management.
Sensitivity analysis, analyzing only patients without treatment restrictions and European patients, was per-
formed. Univariable and multivariable logistic regression analysis was performed to assess associations with 
treatment withdrawal and mortality. Odds ratios (OR) and adjusted odds ratios (aOR) with respective 95% confi-
dence intervals (CI) were calculated. Two multivariable logistic regression models were built for the total cohort, 
(1) using propensity score 1 and (2) using propensity score 2 as covariable. For the sub-group analysis assessing 
associations of parameters with 30-day-mortality in male and female patients, variables with a p value < 0.10 in 
the univariable analysis were included in the multivariable model, then a backward elimination was performed, 
the elimination criterion was 0.10. All tests were two-sided, and a p value of < 0.05 was considered statistically 
significant. SPSS version 23.0 (IBM, USA) and MedCalc Statistical Software version 19.1.3 (MedCalc Software 
bv, Ostend, Belgium; https ://www.medca lc.org; 2019) were used for all statistical analyses.
Ethics approval and consent to participate. A study protocol was provided to participating centers. 
Every participating center obtained ethics approval according to local legislation. A copy of the ethics approval 
was sent to the study coordinator before start of the study.
Consent for publication. Written informed consent was obtained of all included subjects, except for 
patients from VIP2 of sites where study inclusion was explicitly granted without written informed consent.
Results
Study population. In total, 7555 patients were included in this analysis, 3973 (53%) male and 3582 (47%) 
female patients. Admission diagnoses and baseline characteristics are presented in Table 1. Male patients were 
younger compared to female patients, with fewer male patients being over 90 years of age (6% vs. 8%; p < 0.001). 
Male patients were less often frail (CFS > 4; 38% vs. 49%; p < 0.001) and less often suffered from disability 
(ADL ≤ 4; 25% vs. 31%; p < 0.001), and cognitive decline (IQCODE ≥ 3.5; 29% vs. 36%; p < 0.001).
Rates of non-invasive ventilation usage (NIV; 25% vs. 24%; p = 0.29) did not differ between male and female 
patients. Rates of intubation (53% vs. 48%; p < 0.001), renal replacement therapy (13% vs. 8%; p < 0.001) and 
vasoactive drugs (60% vs. 57%; p = 0.003) were higher in male patients compared to females.
Organ failures as assessed by SOFA score was higher in male patients (7 ± 6 vs. 6 ± 6 points; p < 0.001) and the 
length of ICU stay was longer (89 ± 154 vs. 72 ± 131 h; p < 0.001).
The rates of life-sustainment limitation were similar (35% vs. 34%; p = 0.53). In multivariable logistic regres-
sion model, after correction for propensity score 1, male gender was not independently associated with any 
treatment limitation (aOR 0.92 95%CI 0.83–1.03; p = 0.14).
Survival analysis in the total cohort. In univariable analysis in the unbalanced total cohort, 30-day-
mortality was higher (43% vs. 39%; OR 1.18 95%CI 1.08–1.30; p < 0.001) in male patients compared to female 
patients. In multivariable logistic regression models correcting for propensity score 1 (aOR 1.15 95%CI 1.03–
1.27; p = 0.007) as well as propensity score 2 (aOR 1.15 95%CI 1.04–1.27; p = 0.007) male gender was indepen-
dently associated with higher odds for 30-day-mortality. Also, after adjustment for propensity score 2 and length 
Figure 1.  Flow chart of the propensity-score matching process.
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of ICU stay, male sex (aOR 1.13 95%CI 1.03–1.24; p = 0.01) remained independently associated with higher odds 
for 30-day-mortality.
In sensitivity analysis excluding patients with treatment limitation, after correction for propensity score 1 
male gender was independently associated with mortality (aOR 1.19 95%CI 1.04–1.38; p = 0.02) and remained so 
in trend after correction for propensity score 2 (aOR 1.15 95%CI 0.996–1.326; p = 0.056). In sensitivity analysis 
excluding non-European countries, male gender was independently associated with higher rates of 30-day-
mortality after correction for propensity score 1 (aOR 1.14 95%CI 1.03–1.26; p = 0.01) and propensity score 2 
(aOR 1.14 95%CI 1.03–1.27; p = 0.01). Of note, male gender was not associated with ICU mortality (OR 1.08 
95%CI 0.98–1.19; p = 0.14).
Matched‑cohort 1. Baseline characteristics of the matched-cohort 1 (matched on propensity score 1, 
which included only baseline variables, see Fig. 1) are given in Table 2. Risk parameters were evenly distributed 
between male and female patients, but rates of renal replacement therapy were higher (13% vs. 9%; p < 0.001) in 
males as were lengths of ICU stay.
In the paired analysis, the mortality in male VIPs was higher (mean difference 3.33% 95%CI 0.92–5.74%; 
p = 0.007) compared to females. In univariable logistic regression, male gender was associated with higher odds 
for 30-day-mortality (42% vs. 38%; OR 1.15 95%CI 1.04–1.27; p = 0.007). Again, male gender was not (OR 1.02 
95%CI 0.92–1.14; p = 0.69) associated with intra-ICU mortality in this matched cohort.
Table 1.  Baseline characteristics in the total cohort, male versus female VIPs. CFS Clinical Frailty Scale, SOFA 
Sequential Organ Failure Assessment, ADL Activity of Daily Life measured with the Katz Index, IQCODE 
Informant Questionnaire on COgnitive Decline in the Elderly, ICU intensive care unit, NIV non-invasive 
ventilation, SD standard deviation.
Male Female
p valuen = 3973 n = 3582
Age
Median (± IQR) 83 (5) 84 (5) < 0.001
Age > 90 n (%) 227 (5.7%) 288 (8%) < 0.001
Frailty score—CFS
Median (± IQR) 4 (2) 4 (3) < 0.001
Frailty (CFS > 4) n (%) 1519 (38%) 1754 (49%) < 0.001
ADL
Median (± IQR) 6 (1) 6 (2) < 0.001
Disablitiy (ADL ≤ 4) 446 (25%) 489 (31%) < 0.001
IQCODE
Median (± IQR) 3.2 (0.6) 3.3 (0.8) 0.001
Cognitive decline (IQCODE ≥ 3.5) 455 (29%) 486 (36%) < 0.001
median (± IQR) 7 (6) 6 (6) < 0.001
ICU length of stay (hours)
median (± IQR) 89 (154) 72 (131) < 0.001
Treatment withdraw and/or withold (%) 1235 (35) 1342 (34) 0.53
NIV n (%) 933 (25%) 873 (24%) 0.54
Intubation n (%) 2108 (53%) 1728 (48%) < 0.001
Renal replacement therapy n (%) 530 (13%) 296 (8%) < 0.001
Vasoactive drugs n (%) 2397 (60%) 2038 (57%) 0.003
Admission diagnosis
Respiratory failure 928 (23%) 889 (25%)
< 0.001
Circulatory failure 577 (15%) 490 (14%)
Combined circulatory and respiratory failure 493 (12%) 395 (11%)
Sepsis 555 (14%) 451 (13%)
Multitrauma w/o head injury 82 (2%) 58 (2%)
Trauma with head injury 74 (2%) 57 (2%)
Head injury 100 (3%) 83 (2%)
Intoxication 12 (< 1%) 24 (1%)
Cerebral injury (non-traumatic) 231 (6%) 248 (7%)
Emergency surgery 442 (6%) 464 (13%)
Other 479 (12%) 423 (12%)
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Matched‑cohort 2. Table 3 shows baseline characteristics of matched-cohort 2 (matched on propensity 
score 2, which includes baseline variables and information on organ support as well as treatment limitations, see 
Fig. 1). Again, male patients evidenced longer ICU stays (p < 0.001).
Again, in the paired analysis, the mortality in male VIPs was higher (mean difference 3.34% 95%CI 
0.92–5.76%; p = 0.007) compared to females. In univariable logistic regression, male gender was associated with 
higher odds for 30-day-mortality (42% vs. 39%; aOR 1.15 95%CI 1.04–1.27; p = 0.007). Again, gender was not 
associated with ICU mortality (OR 1.02 95%CI 0.92–1.14; p = 0.67) in this matched cohort.
Sub‑group analysis of female and male patients. The presence of frailty (CFS > 4) was associated 
with increased 30-day-mortality in male patients (OR 1.73 95%CI 1.52–1.97; p < 0.001) and remained so in 
multivariable logistic regression (Table 4a).
In female patients frailty (CFS > 4) was associated with 30-day mortality in univariable analysis (OR 1.65 
95%CI 1.44–1.89; p < 0.001) and remained so after correction in multivariable logistic regression (Table 4b).
Furthermore, one-point increases of CFS, as well as SOFA, were independently associated with increased odds 
for 30-day-mortality in multivariable logistic regression in male (Table 4a) as well as in female (Table 4b) VIPs.
Table 2.  Baseline characteristics in the matched cohort 1, male versus female VIPs. CFS Clinical Frailty 
Scale, SOFA Sequential Organ Failure Assessment, ADL Activity of Daily Life measured with the Katz Index, 
IQCODE Informant Questionnaire on COgnitive Decline in the Elderly, ICU intensive care unit, NIV non-
invasive ventilation, SD standard deviation.
Male Female
p valuen = 3183 n = 3183
Age
Median (± IQR) 84 (6) 84 (6) 0.91
Age > 90 n (%) 207 (7%) 195 (6%) 0.57
Frailty score—CFS
Median (± IQR) 4 (3) 4 (3) 0.94
Frailty (CFS > 4) n (%) 1379 (43%) 1409 (44%) 0.46
ADL
Median (± IQR) 6 (2) 6 (2) 0.40
Disablitiy (ADL ≤ 4) 400 (28%) 375 (27%) 0.56
IQCODE
Median (± IQR) 3.3 (0.7) 3.3 (0.7) 0.92
Cognitive decline (IQCODE ≥ 3.5) 404 (32%) 404 (33%) 0.49
SOFA score
Median (± IQR) 7 (6) 6 (6) 0.19
ICU length of stay (hours)
Median (± IQR) 86 (151) 72 (132) < 0.001
Treatment withdraw and/or withold (%) 1054 (33%) 1111 (35%) 0.15
NIV n (%) 789 (25%) 784 (25%) 0.88
Intubation n (%) 1623 (51%) 1559 (49%) 0.10
Renal replacement therapy n (%) 397 (13%) 277 (9%) < 0.001
Vasoactive drugs n (%) 1846 (58%) 1850 (58%) 0.92
Admission diagnosis
Respiratory failure 783 (25%) 786 (25%)
0.99
Circulatory failure 445 (14%) 449 (14%)
Combined circulatory and respiratory failure 353 (11%) 356 (11%)
Sepsis 413 (13%) 410 (13%)
Multitrauma w/o head injury 63 (2%) 55 (2%)
Trauma with head injury 52 (2%) 55 (2%)
Head Injury 78 (3%) 74 (2%)
Intoxication 8 (< 1%) 14 (< 1%)
Cerebral injury (non-traumatic) 203 (6%) 199 (6%)
Emergency surgery 393 (12%) 391 (12%)
Other 392 (12%) 391 (12%)
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Discussion
In this post-hoc analysis of a large group of VIPs included in two international ICU prospective studies, dif-
ferences in the distribution of baseline characteristics and risk factors between male and female patients could 
be found. Further, male sex was associated with increased 30-day-mortality in VIPs and remained so after 
propensity-score adjustments for both baseline characteristics alone and baseline characteristics as well as in-ICU 
variables. However, sex was not associated with ICU-mortality, neither in the total cohort nor in the adjusted 
matched cohorts.
Frailty assessed by CFS was independently associated with 30-day-mortality both in male and female patients 
after adjustment for baseline risk factors. Therefore, CFS could safely be integrated in guiding pre-ICU triage as 
well as intra-ICU triage both in male and female patients.
Male and female patients differed with regards to baseline characteristics, management, and outcomes. Male 
VIPs in this cohort were younger and evidenced lower rates of frailty, disability and cognitive impairment. On the 
other hand, male patients were clinically sicker as expressed by higher SOFA scores. Consequently, unadjusted 
30-day-mortality was higher in male compared to female VIPs. After adjustment for baseline characteristics, 
except for rates of renal replacement therapy, there were no differences in the management of organ support 
between male and female patients. Of note, there are recent data indicating higher susceptibility of kidney to 
injury in male epithelial cells as compared to  female21. Importantly, the rates of treatment limitation did not 
Table 3.  Baseline characteristics in the matched cohort 2, male versus female VIPs. CFS Clinical Frailty Scale, 
SOFA sequential organ failure assessment, ADL Activity of Daily Life measured with the Katz Index, IQCODE 
Informant Questionnaire on COgnitive Decline in the Elderly, ICU intensive care unit, NIV Non-invasive 
ventilation, SD standard deviation.
Male Female
p valuen = 3142 n = 3142
Age
Mean (± SD) 84 (5) 84 (6) 0.61
Age > 90 n (%) 213 (7%) 207 (7%) 0.80
Frailty score—CFS
Mean (± SD) 4 (3) 4 (3) 0.60
Frailty (CFS > 4) n (%) 1355 (43%) 1406 (45%) 0.20
ADL
Mean (± SD) 6 (2) 6 (2) 0.40
Disablitiy (ADL ≤ 4) 390 (27%) 366 (27%) 0.73
IQCODE
Mean (± SD) 3.2 (0.7) 3.3 (0.7) 0.41
Cognitive decline (IQCODE ≥ 3.5) 392 (32%) 390 (33%) 0.38
SOFA score
Mean (± SD) 7 (6) 6 (6) 0.48
ICU length of stay (hours)
Mean (± SD) 78 (136) 72 (133) 0.007
Treatment withdraw and/or withold (%) 1077 (34%) 1080 (34%) 0.96
NIV n (%) 779 (25%) 792 (25%) 0.73
Intubation n (%) 1566 (50%) 1548 (49%) 0.67
Renal replacement therapy n (%) 287 (9%) 285 (9%) 0.93
Vasoactive drugs n (%) 1825 (58%) 1819 (58%) 0.90
Admission diagnosis
Respiratory failure 766 (24%) 781 (25%)
Circulatory failure 453 (14%) 441 (14%)
Combined circulatory and respiratory failure 361 (12%) 362 (12%)
Sepsis 406 (13%) 418 (13%)
Multitrauma w/o head injury 53 (2%) 57 (2%)
Trauma with head injury 51 (2%) 50 (2%)
Head injury 79 (3%) 80 (3%)
Intoxication 7 (< 1%) 7 (< 1%)
Cerebral injury (non-traumatic) 200 (6%) 195 (6%)
Emergency surgery 397 (13%) 375 (12%)
Other 369 (12%) 376 (12%)
Other 369 (12%) 376 (12%)
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differ between male and female VIPs, nor after adjustment in multivariable analysis in the total cohort neither 
in the propensity-matched cohorts.
However, after matching and adjustment for both baseline characteristics alone as well as baseline character-
istics plus ICU management, male gender was still independently associated with increased 30-day-mortality 
in this analysis. Further, male gender remained independently associated with increased 30-day-mortality in a 
sensitivity analysis excluding patients with treatment limitations. Importantly, these results confirm observed 
trends in a recent sub-study of the FROG-ICU study: Hollinger et al. reported increased survival rates in mod-
erately elderly women compared to men, whereas in the overall cohort consisting of more than 2000 critically ill 
patients no sex-related differences in outcomes could be  found13. These findings, relating male gender to adverse 
outcomes, are consistent with previous studies reporting adverse outcomes in male septic  VIPs10. On the other 
hand, this trend in gender difference was not observed for illness-adjusted mortality in a large Austrian cohort 
study on 25,998 patients without age-restriction22. Therefore, the observed sex differences in mortality could 
be age-dependent.
Several factors could contribute to this finding. Certainly, bias and lack of data need to be considered, 
although extensive adjustment for baseline characteristics as well as treatment management was performed 
using propensity scores. However, importantly, only adjustment to available and known covariables is possible. 
First, this study lacks extensive data on comorbidities, which probably influence management and  outcome23. 
However, adjustments for frailty, which is associated with the amount and extent of comorbidities, were per-
formed. Second, further sensitivity analysis and adjustment on both macro- microcirculatory parameters could 
have improved our understanding of this cohort as men have a shorter life expectancy and die at a younger age: 
Their bodies are more worn at a same age which could be underestimated in categorical datasets, like SOFA and 
CFS: continuous data (like biomarkers) could pick up this  difference24. Especially biomarkers such as lactate con-
centration might help to further explain the findings—on the other hand, male sex was independently associated 
with increased mortality after correction for baseline variables including SOFA score which integrates clinical 
findings and laboratory  values25. Also, other important biomarkers such as serum levels of albumin and blood 
urine nitrogen could contribute to the observed sex specific differences in outcome, but were not available for 
this dataset, which is a  limitation26. Third, this cohort of VIPs was not designed to evaluate gender-related differ-
ences and, therefore, this analysis remains of retrospective and thesis-generating character per se. Fourth, other 
potential confounders, such as smoking status or socioeconomic data are lacking, which is another  limitation27. 
Fifth, we observed a sex-specific difference in 30-day-mortality, but not in ICU mortality. We speculate, that this 
could be due to sex-specific differences in management and treatment after discharge from ICU. However, we 
do not have any data available to support this notion, which, therefore, remains speculative. As the overall event 
rate increases from ICU mortality to the 30-day-mortality increases, sex-specific outcome differences could be 
present at ICU discharge, but our dataset be underpowered to detect these differences. Still, to our knowledge, 
this study constitutes the largest cohort of VIPs reporting gender-related outcomes. Therefore, we think that this 
strong signal towards adverse outcomes in male VIPs must be taken seriously.
Several biological and non-biological factors could influence gender-related outcomes. Males and females 
are known to differ in genetic, endocrine, and immunological  factors13,28. Sex-specific treatment algorithms 
and ICU management could contribute to minimizing the observed gender disparities in VIPs. Further, male 
Table 4.  Associations of relevant factors with 30-day mortality in (a) male patients and (b) female patients. 
OR odds ratio, aOR adjusted OR, SOFA Sequential Organ Failure Assessment, CFS Clinical Frailty Scale.
Univariable Multivariable
OR 95%CI p value aOR 95%CI p value
a
Male patients
Age (per year) 1.04 1.02–1.05 < 0.001 1.03 1.01–1.05 0.02
SOFA (per point) 1.18 1.16–1.20 < 0.001 1.11 1.08–1.13 < 0.001
Frailty (per CFS point) 1.21 1.16–1.25 < 0.001 1.13 1.09–1.18 < 0.001
Vasoactive drug (yes vs. no) 2.44 2.13–2.79 < 0.001 0.98 0.81–1.19 0.87
Intubation (yes vs. no) 2.75 2.41–3.14 < 0.001 2.34 1.97–2.78 < 0.001
Renal replacement therapy (yes vs. no) 2.05 1.71–2.47  < 0.001 1.58 1.27–1.98 0.001
Treatment withdrawal or withholding (yes vs. no) 9.02 7.74–10.51 < 0.001 8.99 7.62–10.61 < 0.001
b
Female patients
Age (per year) 1.02 1.002–1.038 0.03 1.02 0.99–1.04 0.17
SOFA (per point) 1.22 1.19–1.14 < 0.001 1.14 1.11–1.17 < 0.001
Frailty (per CFS point) 1.22 1.17–1.27 < 0.001 1.16 1.10–1.21 < 0.001
Vasoactive drug (yes/no) 3.09 2.67–3.57 < 0.001 1.27 1.03–1.55 0.02
Intubation (yes/no) 3.63 3.15–4.18 < 0.001 2.53 2.08–3.07 < 0.001
Renal replacement therapy (yes/no) 3.52 2.73–4.52 < 0.001 3.34 1.74–3.15 < 0.001
Treatment withdrawal or withholding (yes/no) 6.95 5.96–8.10 < 0.001 8.15 6.83–9.72 < 0.001
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and female patients could differ in post-ICU discharge factors. Socioeconomic factors beyond the scope of this 
study could influence  outcomes29. Males and females are known to differ in their readiness to assume risk and 
especially after an ICU stay, gender-specific complications such as falls might in part explain observed distinct 
 outcomes30,31. This notion is supported by the finding that although mortality was consistently higher in males, 
ICU-mortality was similar between males and females, both in the unadjusted and adjusted cohorts. The benefit 
of intensive care in VIP is controversial in general 32. VIPs are known to suffer from high mortality after surviving 
the initial  ICUstay32. Based on our data, male patients might be particularly prone to die after ICU discharge as 
ICU mortality was similar between genders, but 30-day-mortality independently associated with male gender. 
This finding could have several implications. First, male gender could be interpreted as an independent risk 
factor and influence management decisions. Second, if male VIPs are admitted to ICU and survive, post-ICU 
management could be particularly important in male patients. Specific geriatric ICUs and discharge to specialist 
geriatric wards, as well as close interdisciplinary collaboration with social workers and integration of the patient’s 
family, could further improve outcomes in both genders, but especially males. Therefore, not only gender-specific 
ICU treatment but also post-ICU management could help to improve outcomes in general and reduce observed 
gender disparities in VIPs.
Conclusion
Outcomes of elderly intensive care patients evidenced independent sex differences. Male sex was associated with 
adverse 30-day-mortality but not ICU-mortality. Further research to identify potential sex-specific risk factors 
after ICU discharge is warranted.
Data availbility
No additional data available. All data relevant for this study will be given by the authors upon specific request.
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